These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 15638237

  • 21. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
    Croft A, Walsh A, Doecke J, Cooley R, Howlett M, Radford-Smith G.
    Aliment Pharmacol Ther; 2013 Aug; 38(3):294-302. PubMed ID: 23786158
    [Abstract] [Full Text] [Related]

  • 22. Outcome following infliximab therapy in children with ulcerative colitis.
    Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Stephens M, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Grossman A, Tomer G, Kay M, Crandall W, Oliva-Hemker M, Keljo D, LeLeiko N, Markowitz J, Pediatric Inflammatory Bowel Disease Collaborative Research Group.
    Am J Gastroenterol; 2010 Jun; 105(6):1430-6. PubMed ID: 20104217
    [Abstract] [Full Text] [Related]

  • 23. Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis.
    Wenzl HH, Petritsch W, Aichbichler BW, Hinterleitner TA, Fleischmann G, Krejs GJ.
    Z Gastroenterol; 1998 Apr; 36(4):287-93. PubMed ID: 9612926
    [Abstract] [Full Text] [Related]

  • 24. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.
    Maser EA, Deconda D, Lichtiger S, Ullman T, Present DH, Kornbluth A.
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1112-6. PubMed ID: 18928936
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of infliximab in steroid-dependent ulcerative colitis patients.
    Gavalas E, Kountouras J, Stergiopoulos C, Zavos C, Gisakis D, Nikolaidis N, Giouleme O, Chatzopoulos D, Kapetanakis N.
    Hepatogastroenterology; 2007 Jun; 54(76):1074-9. PubMed ID: 17629042
    [Abstract] [Full Text] [Related]

  • 26. Outcome of a conservative approach in severe ulcerative colitis.
    Daperno M, Sostegni R, Scaglione N, Ercole E, Rigazio C, Rocca R, Pera A.
    Dig Liver Dis; 2004 Jan; 36(1):21-8. PubMed ID: 14971812
    [Abstract] [Full Text] [Related]

  • 27. Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response.
    Gonzalez-Lama Y, Fernandez-Blanco I, Lopez-SanRoman A, Taxonera C, Casis B, Tabernero S, Bermejo F, Martinez-Silva F, Mendoza JL, Martinez-Montiel P, Carneros JA, Sanchez F, Maté J, Gisbert JP, Group for the Study of Inflammatory Bowel Diseases from Madrid.
    Hepatogastroenterology; 2008 Jan; 55(86-87):1609-14. PubMed ID: 19102352
    [Abstract] [Full Text] [Related]

  • 28. Infliximab in ulcerative colitis.
    Aberra FN, Lichtenstein GR.
    Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
    [Abstract] [Full Text] [Related]

  • 29. Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis.
    Leblanc S, Allez M, Seksik P, Flourié B, Peeters H, Dupas JL, Bouguen G, Peyrin-Biroulet L, Duclos B, Bourreille A, Dewit O, Bouhnik Y, Michetti P, Chaussade S, Saussure P, Mary JY, Colombel JF, Lémann M, GETAID.
    Am J Gastroenterol; 2011 Apr; 106(4):771-7. PubMed ID: 21386832
    [Abstract] [Full Text] [Related]

  • 30. Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
    Jürgens M, Laubender RP, Hartl F, Weidinger M, Seiderer J, Wagner J, Wetzke M, Beigel F, Pfennig S, Stallhofer J, Schnitzler F, Tillack C, Lohse P, Göke B, Glas J, Ochsenkühn T, Brand S.
    Am J Gastroenterol; 2010 Aug; 105(8):1811-9. PubMed ID: 20197757
    [Abstract] [Full Text] [Related]

  • 31. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

  • 32. Management of refractory fistulizing pouchitis with infliximab.
    Viscido A, Kohn A, Papi C, Caprilli R.
    Eur Rev Med Pharmacol Sci; 2004 May; 8(5):239-46. PubMed ID: 15638238
    [Abstract] [Full Text] [Related]

  • 33. A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks.
    Baudet A, Colombel JF, Cortot A, Dupas JL, Brazier F, Savoye G, Lerebours E, Justum AM, Reimund JM.
    Gastroenterol Clin Biol; 2010 Nov; 34(11):612-7. PubMed ID: 20832218
    [Abstract] [Full Text] [Related]

  • 34. Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.
    Teisner AS, Ainsworth MA, Brynskov J.
    Scand J Gastroenterol; 2010 Dec; 45(12):1457-63. PubMed ID: 20701434
    [Abstract] [Full Text] [Related]

  • 35. Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study.
    Cucchiara S, Romeo E, Viola F, Cottone M, Fontana M, Lombardi G, Rutigliano V, de'Angelis GL, Federici T.
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S260-4. PubMed ID: 18598998
    [Abstract] [Full Text] [Related]

  • 36. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K, Richardson A, Dodd J, Platten J, Shadbolt B, Pavli P.
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [Abstract] [Full Text] [Related]

  • 37. Management of acute severe ulcerative colitis.
    Doherty GA, Cheifetz AS.
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):395-405. PubMed ID: 19673626
    [Abstract] [Full Text] [Related]

  • 38. Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.
    Gustavsson A, Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Verbaan H, Hellström PM, Magnuson A, Halfvarson J, Tysk C.
    Aliment Pharmacol Ther; 2010 Oct; 32(8):984-9. PubMed ID: 20937043
    [Abstract] [Full Text] [Related]

  • 39. Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial.
    Musch E, Andus T, Malek M, Chrissafidou A, Schulz M.
    Z Gastroenterol; 2007 Dec; 45(12):1235-40. PubMed ID: 18080224
    [Abstract] [Full Text] [Related]

  • 40. Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study.
    Mocciaro F, Renna S, Orlando A, Rizzuto G, Sinagra E, Orlando E, Cottone M.
    J Crohns Colitis; 2012 Jul; 6(6):681-6. PubMed ID: 22398101
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.